跳至主要内容
临床试验/NL-OMON48454
NL-OMON48454已完成不适用

Kori-tofu proteins and blood glucose response - KoPro

Asahimatsu support B.V.0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age 50-75yrs
  • BMI >25 kg/m2
  • Having veins suitable for blood sampling via a catheter
  • Having one or more of the following criteria:
  • o HbA1c> 6%
  • o fasting glucose >6.1mmol/L
  • o two-hour glucose levels >7.8 mmol/L on the 75-g oral glucose tolerance test.

排除标准

  • * History of gastro-intestinal surgery or having (serious) gastro-intestinal
  • * History of liver dysfunction (cirrhosis, hepatitis) or liver surgery
  • * Kidney dysfunction (self-reported)
  • * Use of medication/supplements that may influence the study results, such as
  • med-icines known to interfere with glucose homeostasis (judged by our study
  • * Anaemia (Hb values <7.5 for women and <8.5 for men)
  • * Reported slimming, medically prescribed or other extreme diets
  • * Reported weight loss or weight gain of > 5 kg in the month prior to pre-study
  • * Not willing to give up blood donation during the study
  • * Current smokers
  • * Alcohol intake *4 glasses of alcoholic beverages per day
  • * Abuse of drugs
  • * Food allergies for products that we use in the study
  • * Participation in another clinical trial at the same time
  • * Being an employee of the Food, Health & Consumer Research group of
  • Wa-geningen Food & Biobased Research.

研究者

发起方
Asahimatsu support B.V.

相似试验